Skip to content
newprotein.net Explore ingredients
Menu
Cut-away of an airlift fermenter showing swirling pale fungal biomass, with cream mycoprotein crumb

Supplier profile · United Kingdom

ENOUGH (3F BIO): ABUNDA mycoprotein for food

ENOUGH, the trading name of 3F BIO Ltd, makes ABUNDA mycoprotein by fermentation in the Netherlands. Process, factory, applications and buyer checks.

By the New Protein editorial team · Reviewed

Ingredients from 3F BIO Ltd (ENOUGH)

IngredientSource groupProteinStrong at
Mycoprotein Fungal proteins 45 %

What ENOUGH makes

ENOUGH is the trading name of 3FBIO Ltd, a company registered in Scotland with its registered office in Glasgow. It produces ABUNDA, a mycoprotein: the biomass of a filamentous fungus grown in fermentation. The website describes the product as a fermented food ingredient rich in protein and fibre, aimed at food manufacturers that want a meat-style texture without animal raising.

The company states that ABUNDA contains nine essential amino acids, zinc and iron, and that its fibrous structure gives a meaty texture naturally. It presents the ingredient as suitable for vegan, vegetarian and flexitarian diets. Anyone comparing it with other fungal biomass can read the general description of mycoprotein for background on composition, texture and typical limitations.

Its stated aim is to change what people eat rather than how they eat, so that familiar dishes such as a stir fry, burger or sausage can be cooked with no animal involved. The homepage adds a long-range goal of producing one million tonnes of mycoprotein by 2032, which is a company ambition and not a current output figure.

Process and production site

The process described on the website is fermentation in which the fungi are fed the naturally occurring sugars in grains. The result grows into what the company calls a complete food. It describes the method as zero-waste and patented, and says its simplicity makes the product highly scalable. No strain, fermenter type or downstream steps are published.

Production takes place in Sas van Gent in the Netherlands, in a facility that is co-located with a Cargill site. The factory page says it was built in 2022 and covers 150,000 square metres. It gives an initial capacity of 10,000 tonnes per year, with a plan to reach 60,000 tonnes per year within five years.

The news page records further milestones: the completion of the flagship facility, a growth funding round of 40 million euros co-led by World Fund and CPT, and an extended relationship with Cargill. Earlier items mention partnerships with Unilever and Marks and Spencer. Capacity figures remain targets until volumes are confirmed in a supply agreement.

Applications and nutrition claims

ENOUGH positions ABUNDA as a versatile ingredient. The website says it can enter established recipes as a protein and fibre source or inspire new dishes, from burgers and chicken-style products to noodles and snacks. For a developer, a fibrous biomass offers bite and shred, so it is usually tested in whole-muscle analogues before minced formats.

The company makes comparative statements about resource use. Its FAQ says ABUNDA uses 97% less feed and 99% less water than red meat, and 80% less feed and 98% less water than chicken, with lower carbon dioxide emissions as well. These are supplier claims. A buyer who intends to quote them should request the life cycle assessment and its boundaries.

Nutrition statements should also be verified against a specification sheet. Protein content, fibre content, nucleic acid level and moisture decide how the ingredient is declared and dosed. Formulators should ask the company for a technical datasheet, together with allergen information, microbiological limits and the shelf life of the chilled or frozen format supplied.

What a buyer would check

The first check is the format and logistics. Mycoprotein biomass is normally moist and perishable, which affects freight, storage and the production line it enters. Questions about frozen or chilled supply, pack sizes, minimum order quantities and lead times for ABUNDA should be answered in writing before a trial order is placed.

Regulatory status comes next. Fungal biomass is treated as a novel or newly assessed food in some markets and as an established one in others, so the target country matters. A buyer should ask the supplier for the authorisation reference in each market and for the labelling wording it recommends, including any allergen or sensitisation statement.

Finally, supplier stability matters for a new production plant. The company lists investors, industrial partners and customers on its news page, and shares a site with an established agricultural processor that supplies feedstock. A procurement team may still want a quality audit, a second-source plan and a trial run before moving a flagship product to this ingredient.

Frequently asked questions

What is ABUNDA?

ABUNDA is the brand name of the mycoprotein made by ENOUGH. The company describes it as a fermented fungal food ingredient that is rich in protein and fibre and has a fibrous, meat-like texture.

Who is ENOUGH?

ENOUGH is the trading name of 3FBIO Ltd, a company registered in Scotland with its office in Glasgow. Its production site is in Sas van Gent in the Netherlands, next to a Cargill facility.

What does the fungus eat?

The company says its fungi are fed the naturally occurring sugars in grains, and that the process is a zero-waste fermentation. Buyers should ask for the feedstock specification and the country of origin of the grain.

What products can use ABUNDA?

The website names burgers, chicken-style products, noodles and snacks, and says it can be added to established recipes as a protein and fibre source. Each use needs testing for texture and flavour in the actual formulation.